Why The Mesoblast Share Price Is Going Bonkers
Shares in Mesoblast Limited (ASX:MSB) have soared more than 30% in just over 24 hours following yesterday’s announcement of a strategic partnership with a German pharmaceutical business.
Is This The ASX’s Healthiest ETF?
One ASX ETF that could boost the returns of your portfolio is the ETFS S&P Biotech ETF (ASX: CURE). Here are some of the opportunities and risks.